AIP
TPTX

Ameritas Investment Partners’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Ameritas Investment Partners’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,433
Closed -$258K – 3059
2022
Q2 		$258K Sell
3,433
-172
-5% -$7.64K 0.01% 940
2022
Q1 		$97K Hold
3,605
– – ﹤0.01% 1677
2021
Q4 		$172K Hold
3,605
– – 0.01% 1324
2021
Q3 		$239K Hold
3,605
– – 0.01% 1087
2021
Q2 		$281K Buy
3,605
+495
+16% +$36.6K 0.01% 1009
2021
Q1 		$294K Hold
3,110
– – 0.01% 961
2020
Q4 		$379K Buy
3,110
+200
+7% +$21.9K 0.02% 849
2020
Q3 		$254K Buy
2,910
+530
+22% +$36.9K 0.01% 920
2020
Q2 		$154K Hold
2,380
– – 0.01% 1152
2020
Q1 		$106K Hold
2,380
– – 0.01% 1239
2019
Q4 		$148K Buy
2,380
+1,794
+306% +$85.4K 0.01% 1277
2019
Q3 		$22K Hold
586
– – ﹤0.01% 2349
2019
Q2 		$24K Buy
+586
New +$20.9K ﹤0.01% 2353

Ameritas Investment Partners's TPTX Position: Q3 2022 in Review

Ameritas Investment Partners sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 3,433 shares — an estimated $258K sold.

Ameritas Investment Partners first reported a position in TPTX in Q2 2019 and held it in 13 quarters. The position peaked at $379K in Q4 2020. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • Ameritas Investment Partners reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Ameritas Investment Partners sold 3,433 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $258K.
  • Ameritas Investment Partners first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2019 and held it in 13 quarters.
  • Ameritas Investment Partners's Turning Point Therapeutics, Inc. Common Stock position peaked at $379K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Ameritas Investment Partners's 13F filing for Q3 2022, filed 14 Nov 2022.